ELI LILLY & CO (LLY)

US5324571083 - Common Stock

749.92  -3.49 (-0.46%)

After market: 749.92 0 (0%)

News Image
7 hours ago - Market News Video

LLY January 2025 Options Begin Trading

News Image
8 hours ago - The Motley Fool

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Shares of Lilly are cratering, but investors may be surprised to learn what's influencing the volatility.

News Image
a day ago - Chartmill

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

News Image
a day ago - Quartz

Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound

Novo Nordisk and its rival Eli Lilly are visiting HR teams and labor unions across the country to make the case for anti-obesity drugs

News Image
2 days ago - Zacks Investment Research

The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley

Eli Lilly, PepsiCo and Morgan Stanley are included in this Analyst Blog.

News Image
2 days ago - Eli Lilly and Company

Lilly announces changes on board of directors

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1,...

News Image
2 days ago - Zacks Investment Research

Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), PepsiCo, Inc. (PEP) and Morgan Stanley (MS).

News Image
2 days ago - CNBC

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

News Image
3 days ago - CNBC

Cramer's Lightning Round: Eli Lilly is a buy

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

News Image
3 days ago - Eli Lilly and Company

Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for muvalaplin, an investigational once-daily, orally administered...

News Image
3 days ago - Chartmill

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

News Image
3 days ago - Chartmill

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday.

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

News Image
3 days ago - Chartmill

These S&P500 stocks are gapping in today's session

Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

News Image
3 days ago - Zacks Investment Research

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

News Image
4 days ago - BusinessInsider

Hearts and Minds Investments Updates5 Portfolio

Hearts and Minds Investments Ltd (AU:HM1) has released an update. Hearts and Minds Investments Limited (HM1) has unveiled its refreshed 2024/202...

News Image
4 days ago - The Motley Fool

Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now

These stocks have realistic paths to grow larger than Tesla.

News Image
5 days ago - Eli Lilly and Company

Lilly's tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from the SUMMIT Phase 3 trial showing tirzepatide significantly reduced the...

News Image
6 days ago - The Motley Fool

Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

Mergers and acquisitions could make a comeback with Trump headed back to Washington.

News Image
13 days ago - Chartmill

Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.

News Image
15 days ago - Chartmill

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.

Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below.